PROVIDER PROFILE · NPI 1942491436
Arta FarshidiM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,835
Unique beneficiaries
—
Total services
11,333
Distinct HCPCS
18
Medicare payment
$425K
Peer benchmark
Total Medicare services vs. 1,546 Dermatology providers in CA — top quintile (cohort median 2,504).
PRESCRIBING · PART D · 2024
Total Rx claims
578
Beneficiaries
—
Total drug cost
$13K
Distinct drugs
14
Brand share
3.8%
Top prescribed drugs
Hydrocortisone137 claims
Triamcinolone Acetonide98 claims
Ketoconazole94 claims
Metronidazole38 claims
Clobetasol Propionate35 claims
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$449
Payment records
21
By payment type
Food and Beverage$449
Top paying entities
Food and Beverage$449
REFERRAL NETWORK
Where Arta Farshidi's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| PATHOLOGY, INC. | 133 | 397 |
| Unilab Corporation Clinical Laboratory · West Hills, CA | 51 | 116 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE